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ABSTRACT
Use of an ion exchange chromatographic
method and a calorimetric method with thiobarbituric acid
showed that levels of nonenzymatically glucosylated serum
albumin were increased in patients with poorly controlled diabetes mellitus compared to controls. The two methods correlated well (r = 0.99) and clearly discriminated between normal
and poorly controlled diabetic populations. The levels of glymeasured in both populations.
cosylated hemoglobin were also
Several patients apparently in good control based on glycosylated hemoglobin measurements were found to have increased
levels of glucosylated albumin. Because albumin has a shorter
circulating half-life than does the human erythrocyte, the
plasma concentration of glucosylated albumin should be expected to reflect short-term control of hyperglycemia in diabetes. The studies reported here suggest that the level of glucosylated albumin may indeed be a sensitive indicator of moderate
hyperglycemia and of early glucose intolerance.
Recent studies showed that plasma proteins are glucosylated
nonenzymatically by glucose in vitro (1). Glucosylated albumin
was isolated from normal human serum by chromatography
on CM-cellulose and accounted for about 8% of the total circulating albumin in man. The nonenzymatic glucosylation of
albumin appears to proceed through Schiff base formation
between the aldehyde form of the sugar and free amino groups
in protein, followed by Amadori rearrangement to a ketoamine
derivative (Fig. 1) (2). Cyclization of the ketoamine to the
hemiketal structure probably contributes to the stability of the
glucosyl-protein adduct under physiological conditions (2). The
glucosylated albumin yields a positive reaction in the thiobarbituric acid assay for ketoamine derivatives of protein (3) and
is glucosylated primarily at e-amino groups of lysine residues
(refs. 1 and 4, unpublished data).
Levels of nonenzymatically glycosylated hemoglobins, HbAI,
are known to be increased during chronic hyperglycemia in
patients with poorly controlled or untreated diabetes (5), and
the percentage of HbAj correlates well with mean and fasting
blood glucose concentrations (6). Levels of HbA1 may provide
an index of long-term blood glucose control in patients with
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FIG. 1. Proposed reaction scheme for nonenzymatic glucosylation
of albumin.

the same patient group, perhaps because different aspects of
glucose intolerance are reflected by the two different glycosylated proteins.
MATERIALS AND METHODS
Patients of both sexes with diabetes mellitus ranged in age from
10 to 74 years, could be classified as either juvenile- or adultonset diabetics, and were being treated with insulin, oral agents,
or only diet manipulation. The duration of their diabetes ranged
from 3 to 20 years. In all cases, blood sugar control was poor as
judged by records of urinary glucose or serum sugar levels or
both. Control patients had no symptoms of uncontrolled diabetes mellitus and their fasting or 2-hr-postprandial blood sugar
values were normal. Several control patients did have mildly
abnormal results on glucose tolerance tests or had glucosuria
during pregnancy, but there were no clinical data to suggest
sustained hyperglycemia.
Venous blood samples were stored at 40C and the plasma was
separated from the formed elements within 24 hr and usually
within 1 hr. The plasma was stored at -200C until glucosylated
albumin was determined; anticoagulated whole blood was
stored at 4VC until glycosylated hemoglobin was determined.
HbAI was measured after cation exchange chromatography by
determining the absorbance of the two hemoglobin components
at 420 nm by a modification of the method of Schnek and

diabetes.
Because the levels of glucosylated albumin might also be of
value as indicators of the degree of hyperglycemia in diabetes,
studies were undertaken to compare the plasma concentration
of glucosylated albumin in patients with diabetes and in normal
individuals. These studies show that the levels of glucosylated
albumin are increased in patients with poorly controlled diabetes mellitus but do not correlate well with levels of HbAj in
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate
this fact.
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Table 1. Glucosylated hemoglobin and albumin in diabetic
patients and controls
% glucosylated albumin
Thiobarbituric
CM-cellulose
acid method
% HbAj
method
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Controls*

15.1
11.1
14.7
18.3
11.8

17.8
19.2
22.5
21.7
24.3
26.0
18.1
24.6
22.6
20.8
16.3
20.3
22.1
19.5
17.9
16.0
19.8
24.8
23.8
17.4
22.7
12.8
7.0 ± 1.9

25.9
24.3
25.5
25.1
26.9
30.5
20.0
29.7
26.0
23.2
19.0
23.6
25.1
22.0
21.0

8.6
13.2
17.4
14.6
11.8
8.4
10.9
13.6
16.4
10.4
18.5
7.6
23.4
11.5
28.2
11.6
27.2
19.2
20.5
9.2
25.8
15.4
14.8
7.6
8.3 ± 2.2
7.5 i 1.5
* Shown as mean ± SD; for both methods for glucosylated albumin,
n = 25. The value for % HbAj is based on laboratory experience at
Duke University Medical Center.

Schroeder (7). The range of HbAj values was 6-9% for controls
and 6-22% for patients with diabetes.
Serum albumin was purified by affinity chromatography on
Affi-Gel Blue (Bio-Rad) (8), and glucosylated albumin was
determined by CM-cellulose chromatography or by chemical
assay with thiobarbituric acid as described (1, 3). In the chromatographic assay, percentage glucosylated. albumin was calculated by dividing the A280 in the glucosylated peak by the
sum of A280 under both the unglucosylated and glucosylated
peaks. Based on A280 measurements, recovery of protein applied to the columns was quantitative. In the thiobarbituric acid
procedure, accurately weighed albumin samples were assayed
for glucosylated albumin with hydroxymethylfurfural as a
standard; percentage glucosylated albumin was determined
as (mol of hydroxymethylfurfural/mol of albumin) X 100.
RESULTS
The percentages of glycosylated hemoglobin and albumin in
the blood of patients and controls are listed in Table 1. The
normal ranges (mean i SD) of percentage HbAj in the control
population were based on laboratory experience at Duke University Medical Center. Tentative ranges for percentage glucosylated albumin by the chromatographic (CM-cellulose) and
chemical (thiobarbituric acid) methods were based on the
limited sample pool of 25 normal patients. Patients with increased HbAI also had increased glucosylated albumin by both
methods. Four patients with normal HbA1 were found to have
increased glucosylated albumin.
Measurement of glucosylated albumin by the chromatographic procedure is a complex and tedious procedure, requiring purification of total albumin by affinity chromatography followed by dialysis and gradient elution from CM-cellulose (1). It was desirable, therefore, to establish that direct
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FIG. 2. Correlation between glucosylated albumin values determined by chromatographic (CM-cellulose) and chemical (thiobarbituric acid) methods. Sample population included 25 controls
and 22 diabetic patients. Upper limits of normal are indicated by the
rectangle in the lower left corner. 0, Normal; X, diabetic; 0, glucose
intolerant. y = 0.16 + 1.16 x; r = 0.993.

application of the thiobarbituric acid assay to purified, unfractionated albumin could be used for estimation of percentage
glucosylated albumin. The correlation between determinations
of percentage glucosylated albumin by the chemical and
chromatographic procedures was excellent (r = 0.99; y-intercept, <0.5%) (Fig. 2). However, the slope of the correlation
line, m = 1.16, indicated that the chemical assay measured
about 16% more glucosylated albumin than the chromatographic assay (see Discussion). The reproducibility of the two
tests was comparable. Coefficient of variation was <5%
throughout the range 5-30% glucosylated albumin by either
method. It is apparent from Fig. 2 that both the CM-cellulose
and the thiobarbituric acid assays are useful for discriminating
between controls and patients with poorly controlled diabetes.
Three control patients shown in Fig. 2 (open circles) were
classified as glucose intolerant but not diabetic, on the basis of
glucose tolerance tests (see Discussion); levels of glucosylated
albumin for these individuals, determined by either test, were
clearly outside of the normal range, at the low end of the group
with diabetes.
Correlations of percentage glucosylated albumin with percentage HbAj are shown in Fig. 3. The upper limit of normal
for these tests (see Table 1) is defined by the box at the lower
left. It is clear that the normal and diabetic populations occupy
distinctly different regions of this graph. However, several
patients who appear to be in good control based on HbAj levels
are clearly abnormal in their levels of glucosylated albumin.
The correlation between glycosylated hemoglobin and albumin
appears to be complex, and a linear least-squares regression
analysis does not seem appropriate.
DISCUSSION
These studies were undertaken to determine if the blood glucosylated albumin level is increased in patients with poorly
controlled diabetes. The experimental results clearly document
that an increase can be detected by either chromatographic or
chemical assay of glucosylated albumin. The tentative normal
ranges (mean ± 2 SD) for glucosylation of albumin are ap-
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FIG. 3. Correlations between percentage HbAl and percentage glucosylated albumin in normal controls (0) and diabetic patients (X). (A)
Glucosylated albumin by CM-cellulose. (B) Glucosylated albumin by thiobarbituric acid. Upper limits of normal are indicated by the rectangles
in the lower left corners.

proximately 7.0 ± 1.9% and 8.3 i 2.2% by the CM-cellulose and
thiobarbituric acid assays, respectively; levels as high as 30%
are likely in poorly controlled diabetics.
At this point, quantitation of percentage glucosylated albumin is still a cumbersome procedure, requiring first the purification of total albumin and then estimation of percentage
glucosylation. The thioba'rbituric acid assay is more rapid and
more sensitive than the CM-cellulose assay, and the correlation
between the two assays is excellent. The slightly (z46%) higher
estimate of glucosylation in the chemical assay probably results
from detection of glucosylation of albumin at sites that do not
influence its chromatographic mobility on CM-cellulose. We
have, in fact, observed a low level of 16-3Hlglucose incorporation and thiobarbituric acid reactivity in the "unglucosylated"
fraction isolated from CM-cellulose chromatography (1). Thus,
in addition to its speed and sensitivity, the chemical assay
probably provides a better estimate of the amount of glucosylated albumin.
Although both glucosylated albumin and HbAj levels are
increased in diabetics, values for the two tests do not correlate
well within the normal or diabetic group. The poor correlation
suggests that both tests are sensitive to hyperglycemia in diabetes but they are monitoring different aspects of the glucose
intolerance. It may be that HbAj provides an index of relatively
long-term glucose control, perhaps during a span of the previous
1-2 months and glucosylated albumin provides a measure of
control during a shorter interval, possibly the previous 1-2
weeks. This results from the difference between the life-span
of hemoglobin in the blood (1t20 days) (9) and the half-lifeof
circulating albumin (-17 days) (10). Because of the shorter
half-life of albumin, levels of glucosylated albumin should
change more rapidly in response to changes in average blood
glucose concentration. Measurements of glucosylated albumin
may be a better indicator of recent or short-term control and
would supplement data obtainable by assays of HbA1 and other
indices of blood sugar control. In the four patients with normal
HbA1 and increased glucosylated albumin (Fig. 3), it seemed
possible that short-term control was worse than long-term, although independent clinical data to rigorously support this
argument were not available. Measurements of glucosylated

albumin may also be useful for rapidly evaluating alterations
in therapeutic regimens because changes in percentage glucosylated, albumin should be detectable prior to changes in
glycosylated hemoglobin.
It is our impression at this time that the range of increase of
glucosylated albumin (up to 30%) is generally greater than the
corresponding change in HbAl (9-20%) in patients with diabetes.lThe means of normal values for the two determinations
are not significantly different; therefore, glucosylated albumin
may be a moresensitive indicator-of integrated blood glucose
levels than is glucosylated hemoglobin. Measurement of glucosylated albumin also may have some inherent advantages
over glycohemoglobin measurements in certain clinical situations because the -latter are, subject to interference by HbF and
ate sometimes difficult to interpret in hemolyticdisorders and
pregnancy. No significant differences in percentage glucosylated albumin were observed in samples obtained from several
control donors at various times before or during a glucose tolerance test. In addition, because the albumin is purified prior
to analysis, the results of the test are not likely to be affected by
lipemic or hemolyzed specimens.
,
glucosylated albumin
tients with normal glucose tolerance test results by most criteria;
however' two had at least one abnormal blood sugar value
during the test and one had a family history of diabetes mellitus
and was obese. HbAi was not measured in two~of these patients
and was normal in the third. If these patients develop overt
diabetes in the future, one could argue that glucosylated alburnin xnay be a better indicator of early, significant carbohydrate intolerance than a glucose tolerance test or a fasting or
2-hr-postprandial blood sugar value..
Clearly, a more extensive clinical study needs to be performed to determine if the measurement of glucosylated albumin is useful in assessing carbohydrate intolerance or diabetes
control and if there is a correlation between glucosylated plasma
proteins and microvascular complicatio'ns. If measurements of
glucosylated albumin prove useful in the detection and management of diabetes, it may be possible to simplify the assay for
routine use in the clinical laboratory.
Increased

was

detected

in

three

pa-

Biochemistry: Guthrow et al.
This work was supported in part by U.S. Public Health Service Research Grant 1 R01 AM19971, National Institutes of Health Biomedical
Research Support Grant 5S07 RR07160, and the Medical Research
Service of the Veterans Administration.
1. Day, J. F., Thorpe, S. R. & Baynes, J. W. (1979) J. Biol. Chem.
254,595-597.
2. Gottschalk, A. (1972) Glycoproteins (Elsevier, New York), Part
A, pp. 141-157.
3. Fluckiger, R. & Winterhalter, K. H. (1976) FEBS Lett. 71,
356-360.
4. Bailey, A. J., Robins, S. P. & Tanner, M. J. A. (1976) Biochem.
Biophys. Acta 434,51-57.

Proc. Nati. Acad. Sci. USA 76 (1979)

4261

5. Bunn, H. F., Gabbay, K. H. & Gallop, P. M. (1978) Science 200,
21-27.
6. Gonen, B., Rubenstein, A. H., Rochman, H., Tanega, S. P. &

Horwitz, D. L. (1977) Lancet ii, 734-736.
7. Schnek, A. G. & Schroeder, W. A. (1961) J. Am. Chem. Soc. 83,
1471-1478.

8. Travis, J. & Pannell, R. (1973) Clin. Chem. Acta 49, 49-52.
9. Berlin, N. L. (1972) in Hematology, eds. Williams, W. J., Beutler,
E., Erslev, A. J. & Rundles, R. W. (McGraw-Hill, New York), pp.
152-162.
10. Schultze, H. E. & Heremans, J. F. (1966) Molecular Biology of
Human Proteins (Elsevier, New York), pp. 450-517.

